title: [Pharmacotherapy of sleep disorders using benzodiazepine hypnotics and their analogs].
abstract: Benzodiazepine hypnotics and analogs promote the inhibitory neurotransmitter GABA in the brain. The individual substances of this class differ mainly with respect to their elimination half-life. They are all effective hypnotics, but exhibit a number of undesired effects. Hypnotics should be administered generally for the short-term treatment of insomnia, and they should be prescribed for a prolonged time period only exceptionally.
authors.affiliation: Pharmakologisches Institut, Universität Zürich.
authors.forename: A A
authors.initials: AA
authors.lastname: Borbély
mesh_terms: D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use*; D012890:Sleep / Q000187:drug effects; D012893:Sleep Wake Disorders / Q000188:drug therapy*; D012895:Sleep, REM / Q000187:drug effects; D013997:Time Factors
chemical_list: D006993:Hypnotics and Sedatives; D001569:Benzodiazepines
vernacular_title: Pharmakotherapie von Schlafstörungen mit Benzodiazepinhypnotika und Analoga.